Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: No association

Asta Försti; Chunyan Zhao; Elisabeth Israelsson; Karin Dahlman-Wright; Jan Åke Gustafsson; Kari Hemminki

doi:10.1023/A:1024020609833

Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: No association

Asta Försti, Chunyan Zhao, Elisabeth Israelsson, Karin Dahlman-Wright, Jan Åke Gustafsson, Kari Hemminki

Research output: Contribution to journal › Article

40 Scopus citations

Abstract

Polymorphisms in the estrogen receptor beta (ERβ) gene may influence the cellular growth regulating effects of estradiol. In this first association study about breast cancer risk and polymorphisms in the ERβ gene we have screened 219 Finnish sporadic breast cancer cases and 248 ethnically matched male controls. No difference in the allele distribution of the six studied polymorphisms was found between the breast cancer and control groups.

Original language	English (US)
Pages (from-to)	409-413
Number of pages	5
Journal	Breast Cancer Research and Treatment
Volume	79
Issue number	3
DOIs	https://doi.org/10.1023/A:1024020609833
State	Published - Jun 2003

Keywords

Breast cancer
Estrogen receptor beta
Polymorphism

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1023/A:1024020609833

Fingerprint Dive into the research topics of 'Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: No association'. Together they form a unique fingerprint.

Cite this

@article{a135d826f3974ab9990232920fd2667e,

title = "Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: No association",

abstract = "Polymorphisms in the estrogen receptor beta (ERβ) gene may influence the cellular growth regulating effects of estradiol. In this first association study about breast cancer risk and polymorphisms in the ERβ gene we have screened 219 Finnish sporadic breast cancer cases and 248 ethnically matched male controls. No difference in the allele distribution of the six studied polymorphisms was found between the breast cancer and control groups.",

keywords = "Breast cancer, Estrogen receptor beta, Polymorphism",

author = "Asta F{\"o}rsti and Chunyan Zhao and Elisabeth Israelsson and Karin Dahlman-Wright and Gustafsson, {Jan {\AA}ke} and Kari Hemminki",

year = "2003",

month = jun,

doi = "10.1023/A:1024020609833",

language = "English (US)",

volume = "79",

pages = "409--413",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "3",

}

TY - JOUR

T1 - Polymorphisms in the estrogen receptor beta gene and risk of breast cancer

T2 - No association

AU - Försti, Asta

AU - Zhao, Chunyan

AU - Israelsson, Elisabeth

AU - Dahlman-Wright, Karin

AU - Gustafsson, Jan Åke

AU - Hemminki, Kari

PY - 2003/6

Y1 - 2003/6

N2 - Polymorphisms in the estrogen receptor beta (ERβ) gene may influence the cellular growth regulating effects of estradiol. In this first association study about breast cancer risk and polymorphisms in the ERβ gene we have screened 219 Finnish sporadic breast cancer cases and 248 ethnically matched male controls. No difference in the allele distribution of the six studied polymorphisms was found between the breast cancer and control groups.

AB - Polymorphisms in the estrogen receptor beta (ERβ) gene may influence the cellular growth regulating effects of estradiol. In this first association study about breast cancer risk and polymorphisms in the ERβ gene we have screened 219 Finnish sporadic breast cancer cases and 248 ethnically matched male controls. No difference in the allele distribution of the six studied polymorphisms was found between the breast cancer and control groups.

KW - Breast cancer

KW - Estrogen receptor beta

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=0038575826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038575826&partnerID=8YFLogxK

U2 - 10.1023/A:1024020609833

DO - 10.1023/A:1024020609833

M3 - Article

C2 - 12846425

AN - SCOPUS:0038575826

VL - 79

SP - 409

EP - 413

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -